ADD TO MY REPORT
You have 0 pages in your custom report
Bioethics
From the work in our laboratories to our clinical research studies, we are committed to upholding the highest ethical standards across our Family of Companies found in our Ethical Code of Conducts for the Conduct of Research and Development. Our commitment extends to operating our businesses in accordance with accepted international standards for scientific work
Stem Cells
We recognize the potential of stem cell research while understanding the genuine concerns of society and stakeholders about this research. Our Stem Cell Research Policy is the policy that sets forth the ethical and scientific standards in this area.
The policy allows for the use of adult human stem cells, animal stem cells and fetal stem cells from sources such as umbilical cord blood, maternal blood, and placenta or amniocentotic fluid. The use of stem cells for reproductive cloning is prohibited.
A Johnson & Johnson advisory committee, comprised of external bioethics experts, must review any research request involving human embryonic stem cells. Our policy mandates a compelling medical reason for using human embryonic stem cells and requires such studies are conducted according to U.S. guidelines of the National Institutes of Health, the National Academy of Sciences’ National Research Council, and the Institute of Medicine.
Genetic Research and Biotechnology
New technologies to analyze human genes are rapidly advancing our understanding of the human genome and information from genetic research are helping scientists better understand the role genes play in human health. In time, new medicines, diagnostics and treatments are likely to result from this important research. We follow stringent procedures and the highest ethical standards when conducting genetic research, including protecting patient privacy and confidentiality.
Our operating companies are required to follow strict, uniform guidelines for how DNA samples from clinical trials are collected, stored, handled and analyzed. This includes securing informed consent from donors, ensuring DNA samples are collected and stored in an appropriate and ethical manner, and maintaining patient privacy and confidentiality.
In using new biotechnology approaches, our companies:
• Carefully consider potential risks and employ mitigation strategies as appropriate
• Label products containing genetically-modified organisms
consistent with local labeling regulations
• Employ appropriate management and containment approaches
• Adhere to local laws and regulations that govern biotech
applications
Nanotechnology and Genetically Modified Organisms
Johnson & Johnson uses nanotechnology and genetically modified organisms when appropriate. For more information on these issues, please view our Product Quality and Safety section of this website.
Stem Cells
We recognize the potential of stem cell research while understanding the genuine concerns of society and stakeholders about this research. Our Stem Cell Research Policy is the policy that sets forth the ethical and scientific standards in this area.
The policy allows for the use of adult human stem cells, animal stem cells and fetal stem cells from sources such as umbilical cord blood, maternal blood, and placenta or amniocentotic fluid. The use of stem cells for reproductive cloning is prohibited.
A Johnson & Johnson advisory committee, comprised of external bioethics experts, must review any research request involving human embryonic stem cells. Our policy mandates a compelling medical reason for using human embryonic stem cells and requires such studies are conducted according to U.S. guidelines of the National Institutes of Health, the National Academy of Sciences’ National Research Council, and the Institute of Medicine.
Genetic Research and Biotechnology
New technologies to analyze human genes are rapidly advancing our understanding of the human genome and information from genetic research are helping scientists better understand the role genes play in human health. In time, new medicines, diagnostics and treatments are likely to result from this important research. We follow stringent procedures and the highest ethical standards when conducting genetic research, including protecting patient privacy and confidentiality.
Our operating companies are required to follow strict, uniform guidelines for how DNA samples from clinical trials are collected, stored, handled and analyzed. This includes securing informed consent from donors, ensuring DNA samples are collected and stored in an appropriate and ethical manner, and maintaining patient privacy and confidentiality.
In using new biotechnology approaches, our companies:
• Carefully consider potential risks and employ mitigation strategies as appropriate
• Label products containing genetically-modified organisms
consistent with local labeling regulations
• Employ appropriate management and containment approaches
• Adhere to local laws and regulations that govern biotech
applications
Nanotechnology and Genetically Modified Organisms
Johnson & Johnson uses nanotechnology and genetically modified organisms when appropriate. For more information on these issues, please view our Product Quality and Safety section of this website.